Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8678664 | 0.96 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8749123 | 0.96 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL11241926 | 0.96 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1200798 | 0.87 | LMNA (0.33) | LMNATHRBCA2 | |
| SCHEMBL793254 | 0.78 | LMNA (0.41) | LMNATHRBCA2 | |
| Perflubutane SCHEMBL9001079 | 0.78 | LMNA (0.41) | LMNATHRBCA2 | |
| SCHEMBL1223422 | 0.77 | ALDH1A1 (0.30) | LMNA | |
| Perflubutane SCHEMBL111514 | 0.76 | LMNA (0.54) | LMNATHRBCA2CA1MMP1 | |
| Perflubutane SCHEMBL9051673 | 0.76 | LMNA (0.54) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL248576 | 0.75 | LMNA (0.47) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035325-A1 | METHOD FOR PRODUCING 1,2,3,4-TETRACHLORO-1,1,2,3,4,4-HEXAFLUOROBUTANE | KANTO DENKA KOGYO KK (JP) | 2026-02-05 | — | — | US | disclosed |
| US-12358796-B2 | Method for producing fluorine gas | RESONAC CORPORATION (JP) | 2025-07-15 | — | — | US | disclosed |
| CN-119630629-A | Process for producing 1,2,3, 4-tetrachloro-1, 2,3, 4-hexafluorobutane | 关东电化工业株式会社 | 2025-03-14 | — | — | CN | disclosed |
| CN-113906165-B | Method for producing fluorine gas | 株式会社力森诺科 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024024871-A1 | METHOD FOR PRODUCING 1,2,3,4-TETRACHLORO-1,1,2,3,4,4-HEXAFLUOROBUTANE | 関東電化工業株式会社 | 2024-02-01 | — | — | WO | disclosed |
| EP-3741736-B1 | METHOD FOR PRODUCING TETRAFLUOROMETHANE | RESONAC CORP (JP) | 2023-08-02 | — | — | EP | disclosed |
| CN-111566077-B | Method for producing tetrafluoromethane | 昭和电工株式会社 | 2023-03-24 | — | — | CN | disclosed |
| US-20220234890-A1 | METHOD FOR PRODUCING FLUORINE GAS | SHOWA DENKO K.K. (JP) | 2022-07-28 | — | — | US | disclosed |
| EP-4023792-A1 | FLUORINE GAS PRODUCTION METHOD | Showa Denko K.K. (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-113906165-A | Method for producing fluorine gas | 昭和电工株式会社 | 2022-01-07 | — | — | CN | disclosed |
| US-11034636-B2 | Method for producing tetrafluoromethane | SHOWA DENKO K.K. (JP) | 2021-06-15 | — | — | US | disclosed |
| US-20200407295-A1 | METHOD FOR PRODUCING TETRAFLUOROMETHANE | SHOWA DENKO K.K. (JP) | 2020-12-31 | — | — | US | disclosed |
| EP-3741736-A1 | METHOD FOR PRODUCING TETRAFLUOROMETHANE | Showa Denko K.K. (JP) | 2020-11-25 | — | — | EP | disclosed |
| CN-111566077-A | Method for producing tetrafluoromethane | 昭和电工株式会社 | 2020-08-21 | — | — | CN | disclosed |
| WO-2019142626-A1 | METHOD FOR PRODUCING TETRAFLUOROMETHANE | 昭和電工株式会社 | 2019-07-25 | — | — | WO | disclosed |
| US-8404906-B2 | Process for producing 1,2,3,4-tetrachlorohexafluorobutane | SHOWA DENKO K.K. (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110112341-A1 | PROCESS FOR PRODUCING 1,2,3,4-TETRACHLOROHEXAFLUOROBUTANE | SHOWADENKO K.K. (JP) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035325-A1 | METHOD FOR PRODUCING 1,2,3,4-TETRACHLORO-1,1,2,3,4,4-HEXAFLUOROBUTANE | CYP2F1, CLIC1, CYP4F2 | LMNA 2084/4885THRB 885/4885CA2 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.